Work

Conscience November 2024 Policy Brief - National strategy for Drugs for Rare Disease Agreement

Year: 2024

Type: article

Abstract: Agreement between Canada and Newfoundland on Rare Diseases On November 15, 2024, the governments of Canada and of Newfoundland signed the National strategy for Drugs for Rare Disease Agreement (DRD) to support enhanced access to early diagnosis, screening for rare diseases, and improved access to existing and new drugs for rare diseases. This policy brief explains the unmet needs of rare disease patients and how this is just the first part of Canada's longer term strategy to invest in discovering new medicines for rare diseases.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14207516

Author: Jolicoeur-Becotte, Marie

Institution: McGill University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDGs: Good health and well-being, Partnerships for the goals

Open Access status: green

OpenAlex ID: W6911639305

FWCI:

Cites:

Cited by:

Related to: